Showing results (221-230 of 311) with videos related to
Sort By:
Pageof 32
Seminars in Oncology|December 1, 1996
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancerP F Conte, E Baldini, A Michelotti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trialP F Conte, P Pronzato, A Rubagotti, et al.Applied Pathology|January 1, 1989
IgA mesangial nephropathy associated with renal cell carcinomaA Sessa, A Volpi, C Tetta, et al.British Journal of Cancer|February 1, 1989
Phase II study of lonidamine in metastatic breast cancerP Pronzato, D Amoroso, G Bertelli, et al.Tumori|April 30, 1988
Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot studyP F Conte, M Bruzzone, S Chiara, et al.European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markersP Collecchi, E Baldini, P Giannessi, et al.Journal of Environmental Radioactivity|January 24, 2012
Environmental radioactivity analyses in Italy following the Fukushima Dai-ichi nuclear accidentM Barsanti, F Conte, I Delbono, et al.International Journal of Cancer|October 15, 1987
Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic resultsP F Conte, A Alama, G Bertelli, et al.Seminars in Oncology|February 1, 1996
Activity and safety of epirubicin plus paclitaxel in advanced breast cancerP F Conte, A Michelotti, E Baldini, et al.American Journal of Clinical Oncology|December 1, 1996
Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancerE Baldini, C Tibaldi, E Pfanner, et al.Pageof 32